Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Custers

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2025
Cleavage Under Targets & Release Using Nuclease (CUT&RUN) Protocols for the Study of Genetic and Epigenetic Regulation in CancerStefan Custers, Erika Apel, Yujin Suk, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2024
Cancer Stem Cells: Current Challenges and Future PerspectivesMuhammad Vaseem Shaikh, Stefan Custers, Alisha Anand, et al.
Frontiers in Oncology|February 14, 2022
The Road to CAR T-Cell Therapies for Pediatric CNS Tumors: Obstacles and New AvenuesIan Burns, William D Gwynne, Yujin Suk, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2025
CRISPR-Cas9-Guided Genetic Manipulation of Patient-Derived Brain Tumor CellsYujin Suk, Erika Apel, Stefan Custers, et al.
Acta Neuropathologica Communications|October 23, 2023
Correction to: Dynamic profiling of medulloblastoma surfaceomeDavid Bakhshinyan, Yujin Suk, Laura Kuhlmann, et al.
Acta Neuropathologica Communications|July 10, 2023
Dynamic profiling of medulloblastoma surfaceomeDavid Bakhshinyan, Yujin Suk, Laura Kuhlmann, et al.
Scientific Reports|October 16, 2025
CRISPR screen reveals SOX2 as a critical regulator of CD133 and cellular stress response in glioblastomaNeil Savage, Etienne Danis, Chirayu R Chokshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2025
Leveraging Medulloblastoma Clonal Dynamics to Overcome Treatment ResistanceDavid Bakhshinyan, Stefan Custers, Laura Escudero, et al.
Science Advances|December 8, 2021
Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrenceDavid Bakhshinyan, Ashley A Adile, Jeff Liu, et al.
Cancer Cell|November 11, 2022
Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastomaWilliam D Gwynne, Yujin Suk, Stefan Custers, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2025
Cleavage Under Targets & Release Using Nuclease (CUT&RUN) Protocols for the Study of Genetic and Epigenetic Regulation in CancerStefan Custers, Erika Apel, Yujin Suk, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2024
Cancer Stem Cells: Current Challenges and Future PerspectivesMuhammad Vaseem Shaikh, Stefan Custers, Alisha Anand, et al.
Frontiers in Oncology|February 14, 2022
The Road to CAR T-Cell Therapies for Pediatric CNS Tumors: Obstacles and New AvenuesIan Burns, William D Gwynne, Yujin Suk, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2025
CRISPR-Cas9-Guided Genetic Manipulation of Patient-Derived Brain Tumor CellsYujin Suk, Erika Apel, Stefan Custers, et al.
Acta Neuropathologica Communications|October 23, 2023
Correction to: Dynamic profiling of medulloblastoma surfaceomeDavid Bakhshinyan, Yujin Suk, Laura Kuhlmann, et al.
Acta Neuropathologica Communications|July 10, 2023
Dynamic profiling of medulloblastoma surfaceomeDavid Bakhshinyan, Yujin Suk, Laura Kuhlmann, et al.
Scientific Reports|October 16, 2025
CRISPR screen reveals SOX2 as a critical regulator of CD133 and cellular stress response in glioblastomaNeil Savage, Etienne Danis, Chirayu R Chokshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2025
Leveraging Medulloblastoma Clonal Dynamics to Overcome Treatment ResistanceDavid Bakhshinyan, Stefan Custers, Laura Escudero, et al.
Science Advances|December 8, 2021
Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrenceDavid Bakhshinyan, Ashley A Adile, Jeff Liu, et al.
Cancer Cell|November 11, 2022
Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastomaWilliam D Gwynne, Yujin Suk, Stefan Custers, et al.
Pageof 2